La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Antiparkinsonien »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antioxydant < Antiparkinsonien < Antipsychotique  Facettes :

List of bibliographic references indexed by Antiparkinsonien

Number of relevant bibliographic references: 128.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B82 (2014) Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]The effects of dopaminergic medication on dynamic decision making in Parkinson's disease
000B85 (2014) Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis]Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
000B86 (2014) Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
001038 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001074 (2013) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Dopaminergic contributions to distance estimation in Parkinson's disease: A sensory-perceptual deficit?
001076 (2013) Jolyn N. A. D'Andrea [Canada] ; Angela M. Haffenden [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Bradley G. Goodyear [Canada]Degradation of stored movement representations in the parkinsonian brain and the impact of levodopa
001082 (2013) Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada]An update on amine oxidase inhibitors: Multifaceted drugs
001483 (2012) Dominic Nadeau [Canada] ; Isabelle Giroux [Canada] ; Julie Dufour [Canada] ; Martine Simard [Canada]Jeu pathologique chez les patients atteints de la maladie de Parkinson
001966 (2011) A. Q. Rana [Canada] ; J. Depradine [Canada]Abdominal Pain: A Symptom of Levodopa End of Dose Wearing off in Parkinson's Disease
001C80 (2010) Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada]Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
001D19 (2010) Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada]Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
002078 (2009) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Maxime Levesque [Canada] ; Mark Chebli [Canada] ; Maxime Parent [Canada] ; Richard Courtemanche [Canada] ; Pierre J. Blanchet [Canada]Motor sequence learning in primate : Role of the D2 receptor in movement chunking during consolidation
002121 (2009) C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Robert Hauser [États-Unis] ; Paul D. Feigin [Israël] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; William Langston [États-Unis] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
002366 (2008) Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [États-Unis] ; Pershia Samadi [Canada] ; Paul J. Bedard [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Therese Di Paolo [Canada]Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
002916 (2006) Jon Doan [Canada] ; Ian Q. Whishaw [Canada] ; Sergio M. Pellis [Canada] ; Oksana Suchowersky [Canada] ; Lesley A. Brown [Canada]Motor deficits in parkinsonian reaching : Dopa-sensitivity influenced by real-world task constraint
002B08 (2005) ZHIGANG HONG [États-Unis] ; Andrew J. Smith [États-Unis] ; Stephen L. Archer [Canada] ; Xi-Chen Wu [Canada] ; Daniel P. Nelson [États-Unis] ; Douglas Peterson [États-Unis] ; Gerhard Johnson [États-Unis] ; E. Kenneth Weir [États-Unis]Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction
002B10 (2005) Kyle G. Melvin [Canada] ; Jon Doan [Canada] ; Sergio M. Pellis [Canada] ; Lesley Brown [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada]Pallidal deep brain stimulation and L-dopa do not improve qualitative aspects of skilled reaching in parkinson's disease
002B21 (2005) Anthony O'Hagan [Royaume-Uni] ; Christopher Mccabe [Royaume-Uni] ; Ron Akehurst [Royaume-Uni] ; Alan Brennan [Royaume-Uni] ; Andrew Briggs [Royaume-Uni] ; Karl Claxton [Royaume-Uni] ; Elisabeth Fenwick [Royaume-Uni] ; Dennis Fryback [États-Unis] ; Mark Sculpher [Royaume-Uni] ; David Spiegelhalter [Royaume-Uni] ; Andrew Willan [Canada]Incorporation of uncertainty in health economic modelling studies
002D24 (2004) Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique]Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
002D36 (2004) Naila Ismayilova [Canada] ; Alan Crossman [Canada] ; Alexei Verkhratsky [Canada] ; Jonathan Brotchie [Canada]Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats
002E96 (2003) W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]Treatment of Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Antiparkinsonien" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Antiparkinsonien" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Antiparkinsonien
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022